285 related articles for article (PubMed ID: 10759405)
1. Matrix metalloproteinase inhibitors: applications in oncology.
Yip D; Ahmad A; Karapetis CS; Hawkins CA; Harper PG
Invest New Drugs; 1999; 17(4):387-99. PubMed ID: 10759405
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors as anticancer agents.
Konstantinopoulos PA; Karamouzis MV; Papatsoris AG; Papavassiliou AG
Int J Biochem Cell Biol; 2008; 40(6-7):1156-68. PubMed ID: 18164645
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase inhibitors: present achievements and future prospects.
Denis LJ; Verweij J
Invest New Drugs; 1997; 15(3):175-85. PubMed ID: 9387040
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases. Novel targets for directed cancer therapy.
Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
[TBL] [Abstract][Full Text] [Related]
6. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
7. Progress in the development of matrix metalloproteinase inhibitors.
Tu G; Xu W; Huang H; Li S
Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibition: a review of anti-tumour activity.
Brown PD; Giavazzi R
Ann Oncol; 1995 Dec; 6(10):967-74. PubMed ID: 8750146
[TBL] [Abstract][Full Text] [Related]
10. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
Jones L; Ghaneh P; Humphreys M; Neoptolemos JP
Ann N Y Acad Sci; 1999 Jun; 880():288-307. PubMed ID: 10415874
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
Rasmussen HS; McCann PP
Pharmacol Ther; 1997; 75(1):69-75. PubMed ID: 9364582
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Mitsiades N; Poulaki V; Mitsiades CS; Anderson KC
Expert Opin Investig Drugs; 2001 Jun; 10(6):1075-84. PubMed ID: 11772236
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
Das S; Amin SA; Jha T
Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437
[TBL] [Abstract][Full Text] [Related]
14. Clinical studies with matrix metalloproteinase inhibitors.
Brown PD
APMIS; 1999 Jan; 107(1):174-80. PubMed ID: 10190295
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
Rudek MA; Venitz J; Figg WD
Pharmacotherapy; 2002 Jun; 22(6):705-20. PubMed ID: 12066962
[TBL] [Abstract][Full Text] [Related]
16. Role of matrix metalloproteinases and their inhibitors in pancreatic cancer.
Evans JD; Ghaneh P; Kawesha A; Neoptolemos JP
Digestion; 1997; 58(6):520-8. PubMed ID: 9438596
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
Fingleton B
Expert Opin Ther Targets; 2003 Jun; 7(3):385-97. PubMed ID: 12783574
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
Pavlaki M; Zucker S
Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review).
Duffy MJ; McCarthy K
Int J Oncol; 1998 Jun; 12(6):1343-8. PubMed ID: 9592197
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase inhibitors.
Brown PD
Breast Cancer Res Treat; 1998; 52(1-3):125-36. PubMed ID: 10066077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]